Carcinoma de tiroides una verdadera pandemia?
| Contribuinte(s) |
Alex, Valenzuela |
|---|---|
| Data(s) |
22/09/2015
|
| Resumo |
El diagnóstico de cáncer de tiroides se ha incrementado y las posibilidades de detección de una enfermedad subclínica son altas, toda vez que disponemos de herramientas de detección más sensibles y de fácil acceso. Por ende, el clínico requiere conocer la historia natural del nódulo tiroideo y del carcinoma papilar de tiroides de bajo riesgo para brindar a su paciente el mejor tratamiento basado en la evidencia clínica. El objetivo de esta revision es reconocer los elementos clínicos que han condicionado el aumento inusitado de casos de cáncer de tiroides. Conclusión: El sobrediagnóstico del cáncer de tiroides es una realidad, que se posibilita por el uso extendido de biopsia por aspiración con aguja fina ((BACAF)) después de la detección de un nódulo tiroideo, en gran parte de manera incidental, sin acarrear la mayoría de las veces un mejor pronóstico después de su tratamiento. |
| Formato |
application/pdf |
| Identificador | |
| Idioma(s) |
spa |
| Publicador |
Facultad de medicina |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
instname:Universidad del Rosario reponame:Repositorio Institucional EdocUR Ahn, Hyeong Sik, Hyun Jung Kim, and H. Gilbert Welch. 2014. “Korea’s Thyroid-Cancer ‘epidemic’-Screening and Overdiagnosis.” The New England Journal of Medicine 371 (19): 1765–67. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, David S. Cooper, Gerard M. Doherty, Bryan R. Haugen, Bryan R. Hauger, Richard T. Kloos, Stephanie L. Lee, et al. 2009. “Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer.” Thyroid: Official Journal of the American Thyroid Association 19 (11): 1167–1214. Baker, Laurence C., Scott W. Atlas, and Christopher C. Afendulis. 2008. “Expanded Use of Imaging Technology and the Challenge of Measuring Value.” Health Affairs 27 (6): 1467–78. Baker, Stephen R., and Waseem A. Bhatti. 2006. “The Thyroid Cancer Epidemic: Is It the Dark Side of the CT Revolution?” European Journal of Radiology 60 (1): 67–69. Chen, Amy Y., Ahmedin Jemal, and Elizabeth M. Ward. 2009. “Increasing Incidence of Differentiated Thyroid Cancer in the United States, 1988–2005.” Cancer 115 (16). Wiley Subscription Services, Inc., A Wiley Company: 3801–7. Cheng, Iona, John S. Witte, Laura A. McClure, Sarah J. Shema, Myles G. Cockburn, Esther M. John, and Christina A. Clarke. 2009. “Socioeconomic Status and Prostate Cancer Incidence and Mortality Rates among the Diverse Population of California.” Cancer Causes & Control: CCC 20 (8): 1431–40. Cooper, David S., Gerard M. Doherty, Bryan R. Haugen, Richard T. Kloos, Stephanie L. Lee, Susan J. Mandel, Ernest L. Mazzaferri, Bryan McIver, Steven I. Sherman, and R. Michael Tuttle. 2006. “Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce.” Thyroid: Official Journal of the American Thyroid Association 16 (2): 109–42. Cronan, John J. 2008. “Thyroid Nodules: Is It Time to Turn off the US Machines?” Radiology 247 (3): 602–4. Davies, Louise, and H. Gilbert Welch. 2006. “Increasing Incidence of Thyroid Cancer in the United States, 1973-2002.” JAMA: The Journal of the American Medical Association 295 (18): 2164–67. ———. 2014. “Current Thyroid Cancer Trends in the United States.” JAMA Otolaryngology-- Head & Neck Surgery 140 (4): 317–22. Durante, Cosimo, Giuseppe Costante, Giuseppe Lucisano, Rocco Bruno, Domenico Meringolo, Alessandra Paciaroni, Efisio Puxeddu, et al. 2015. “The Natural History of Benign Thyroid Nodules.” JAMA: The Journal of the American Medical Association 313 (9): 926–35. Filetti, Sebastiano, Cosimo Durante, and Massimo Torlontano. 2006. “Nonsurgical Approaches to the Management of Thyroid Nodules.” Nature Clinical Practice. Endocrinology & Metabolism 2 (7): 384–94. Ghori, Farah Y., Danielle R. Gutterman-Litofsky, Amin Jamal, Sai-Ching J. Yeung, Ridha Arem, and Steven I. Sherman. 2002. “Socioeconomic Factors and the Presentation, Management, and Outcome of Patients with Differentiated Thyroid Carcinoma.” Thyroid: Official Journal of the American Thyroid Association 12 (11): 1009–16. Giordano, Davide, Roberto Valcavi, Geoffrey B. Thompson, Corrado Pedroni, Luigi Renna, Paolo Gradoni, and Verter Barbieri. 2012. “Complications of Central Neck Dissection in Patients with Papillary Thyroid Carcinoma: Results of a Study on 1087 Patients and Review of the Literature.” Thyroid: Official Journal of the American Thyroid Association 22 (9): 911–17. Harach, H. R., K. O. Franssila, and V. M. Wasenius. 1985. “Occult Papillary Carcinoma of the Thyroid. A ‘Normal’ Finding in Finland. A Systematic Autopsy Study.” Cancer 56 (3): 531–38. Hay, Ian D., Erik J. Bergstralh, John R. Goellner, Janet R. Ebersold, Clive S. Grant, and Others. 1993. “Predicting Outcome in Papillary Thyroid Carcinoma: Development of a Reliable Prognostic Scoring System in a Cohort of 1779 Patients Surgically Treated at One Institution during 1940 through 1989.” SURGERY-SAINT LOUIS- 114. MOSBY-YEAR BOOK INC: 1050–1050. Ho, Allen S., Louise Davies, Iain J. Nixon, Frank L. Palmer, Laura Y. Wang, Snehal G. Patel, Ian Ganly, Richard J. Wong, R. Michael Tuttle, and Luc G. T. Morris. 2015. “Increasing Diagnosis of Subclinical Thyroid Cancers Leads to Spurious Improvements in Survival Rates.” Cancer 121 (11): 1793–99. Horner, M. J., Lag Ries, M. Krapcho, N. Neyman, R. Aminou, N. Howlader, S. F. Altekruse, et al. 2009. “SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD.” Howlader, N., A. M. Noone, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, S. F. Altekruse, et al. 2011. “SEER Cancer Statistics Review, 1975--2008. Bethesda, MD: National Cancer Institute; 2011.” Also Available Online Last Accessed December 1. Ito, Yasuhiro, Akira Miyauchi, Hiroyuki Inoue, Mitsuhiro Fukushima, Minoru Kihara, Takuya Higashiyama, Chisato Tomoda, Yuuki Takamura, Kaoru Kobayashi, and Akihiro Miya. 2010. “An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients.” World Journal of Surgery 34 (1): 28–35. Iyer, N. Gopalakrishna, Luc G. T. Morris, R. Michael Tuttle, Ashok R. Shaha, and Ian Ganly. 2011. “Rising Incidence of Second Cancers in Patients with Low-Risk (T1N0) Thyroid Cancer Who Receive Radioactive Iodine Therapy.” Cancer 117 (19): 4439–46. Jung, Kyu-Won, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Hong Gwan Seo, and Jin-Soo Lee. 2013. “Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010.” Cancer Research and Treatment: Official Journal of Korean Cancer Association 45 (1): 1–14. Kazakov, V. S., E. P. Demidchik, and L. N. Astakhova. 1992. “Thyroid Cancer after Chernobyl.” Nature 359 (6390): 21. Kent, William D. T., Stephen F. Hall, Phillip A. Isotalo, Robyn L. Houlden, Ralph L. George, and Patti A. Groome. 2007. “Increased Incidence of Differentiated Thyroid Carcinoma and Detection of Subclinical Disease.” CMAJ: Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne 177 (11): 1357–61. Kilfoy, Briseis A., Tongzhang Zheng, Theodore R. Holford, Xuesong Han, Mary H. Ward, Andreas Sjodin, Yaqun Zhang, et al. 2008. “International Patterns and Trends in Thyroid Cancer Incidence, 1973–2002.” Cancer Causes & Control: CCC 20 (5). Springer Netherlands: 525–31. Leenhardt, L., M. O. Bernier, M. H. Boin-Pineau, B. Conte Devolx, R. Maréchaud, P. Niccoli-Sire, M. Nocaudie, et al. 2004. “Advances in Diagnostic Practices Affect Thyroid Cancer Incidence in France.” European Journal of Endocrinology / European Federation of Endocrine Societies 150 (2): 133–39. Lee, Seung Hun, Tae Yong Kim, Jin-Sook Ryu, Gyungyub Gong, Won Bae Kim, Seong Chul Kim, Suck Joon Hong, and Young Kee Shong. 2008. “Trends Analysis of Characteristics of Thyroid Cancer Patients in One Medical Center.” Journal of Korean Endocrine Society 23 (1): 35. Lee, Tae-Jin, Sun Kim, Hong-Jun Cho, and Jae-Ho Lee. 2012. “The Incidence of Thyroid Cancer Is Affected by the Characteristics of a Healthcare System.” Journal of Korean Medical Science 27 (12): 1491–98. Mackillop, W. J., J. Zhang-Salomons, C. J. Boyd, and P. A. Groome. 2000. “Associations between Community Income and Cancer Incidence in Canada and the United States.” Cancer 89 (4): 901–12. Mandel, Susan J. 2004. “Diagnostic Use of Ultrasonography in Patients with Nodular Thyroid Disease.” Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 10 (3): 246–52. McIver, B., I. D. Hay, D. F. Giuffrida, C. E. Dvorak, C. S. Grant, G. B. Thompson, J. A. van Heerden, and J. R. Goellner. 2001. “Anaplastic Thyroid Carcinoma: A 50-Year Experience at a Single Institution.” Surgery 130 (6): 1028–34. Morris, Luc G. T., and David Myssiorek. 2010. “Improved Detection Does Not Fully Explain the Rising Incidence of Well-Differentiated Thyroid Cancer: A Population-Based Analysis.” American Journal of Surgery 200 (4): 454–61. Morris, Luc G. T., Andrew G. Sikora, Tor D. Tosteson, and Louise Davies. 2013. “The Increasing Incidence of Thyroid Cancer: The Influence of Access to Care.” Thyroid: Official Journal of the American Thyroid Association 23 (7): 885–91. Pacini, Furio, Martin Schlumberger, Henning Dralle, Rossella Elisei, Johannes W. A. Smit, Wilmar Wiersinga, and European Thyroid Cancer Taskforce. 2006. “European Consensus for the Management of Patients with Differentiated Thyroid Carcinoma of the Follicular Epithelium.” European Journal of Endocrinology / European Federation of Endocrine Societies 154 (6): 787–803. Papini, Enrico, Rinaldo Guglielmi, Antonio Bianchini, Anna Crescenzi, Silvia Taccogna, Francesco Nardi, Claudio Panunzi, Roberta Rinaldi, Vincenzo Toscano, and Claudio M. Pacella. 2002. “Risk of Malignancy in Nonpalpable Thyroid Nodules: Predictive Value of Ultrasound and Color-Doppler Features.” The Journal of Clinical Endocrinology and Metabolism 87 (5): 1941–46. Pellegriti, Gabriella, Claudia Scollo, Gabriella Lumera, Concetto Regalbuto, Riccardo Vigneri, and Antonino Belfiore. 2004. “Clinical Behavior and Outcome of Papillary Thyroid Cancers Smaller than 1.5 Cm in Diameter: Study of 299 Cases.” The Journal of Clinical Endocrinology and Metabolism 89 (8): 3713–20. Ron, E., J. H. Lubin, R. E. Shore, K. Mabuchi, B. Modan, L. M. Pottern, A. B. Schneider, M. A. Tucker, and J. D. Boice Jr. 1995. “Thyroid Cancer after Exposure to External Radiation: A Pooled Analysis of Seven Studies.” Radiation Research 141 (3): 259–77. Ron, E., and A. F. Saftlas. 1996. “Head and Neck Radiation Carcinogenesis: Epidemiologic Evidence.” Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 115 (5): 403–8. Sprague, Brian L., Shaneda Warren Andersen, and Amy Trentham-Dietz. 2008. “Thyroid Cancer Incidence and Socioeconomic Indicators of Health Care Access.” Cancer Causes & Control: CCC 19 (6): 585–93. Weiss, W. 1979. “Changing Incidence of Thyroid Cancer.” Journal of the National Cancer Institute 62 (5): 1137–42. Welch, H. Gilbert, and William C. Black. 2010. “Overdiagnosis in Cancer.” Journal of the National Cancer Institute 102 (9): 605–13. Youserm, D. M., T. Huang, L. A. Loevner, and C. P. Langlotz. 1997. “Clinical and Economic Impact of Incidental Thyroid Lesions Found with CT and MR.” AJNR. American Journal of Neuroradiology 18 (8): 1423–28. TEME |
| Palavras-Chave | #Endocrinología #611.4 #Sistema endocrino #Enfermedades de la tiroides |
| Tipo |
info:eu-repo/semantics/bachelorThesis info:eu-repo/semantics/acceptedVersion |
